thoracic aortic pathologies I71
Conditions
Interventions
Group 1: Clinical, radiological and genetic data of thoracic aortic pathologies are prospectively collected and evaluated.
Sponsors
Universitätsklinikum Heidelberg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patient's ability to consent, confirmed diagnosis of acute aortic pathology (PAU, IMH, type Stanford B aortic dissection, aortic aneurysm) of the thoracic aorta (without involvement of the aortic arch or ascending aorta). The origin of the aortic pathology must be in the area of the thoracic aorta, but can also spread to the abdominal aorta or iliac arteries.
Exclusion criteria
Exclusion criteria: Inadequate anonymization, lack of informed consent from study participants, patients are not able to give consent, traumatic aortic pathology due to accident, data transfer outside the Heidelberg Portal for Medical Data Models (https://medical-data-models.org)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main criterion is to examine whether genetic mutations in candidate genes or genetic risk variants can be identified in affected patients | — |
Secondary
| Measure | Time frame |
|---|---|
| As secondary criteria, the clinical outcome for the therapy options (surgical therapy, endovascular therapy, conservative therapy) will be examined and evaluated. | — |
Countries
Germany
Contacts
Public ContactPhilipp Erhart
Universitätsklinikum Heidelberg
Outcome results
None listed